Angiographic Results of a novel Novolimus Eluting Bioresorbable Coronary Scaffold System (NEBCSS) for the treatment of single de-novo coronary artery lesions: 6 month Serial QCA analysis results from the pivotal, prospective, multicentre, DESolve NX Trial

[摘要]

[发布日期] 2013-10-29